Does rationalisation of roles mean they have worked out some are not earning their money clearly?? As staffing costs have continued to blowout whilst revenue has gone nowhere?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
